Lucid Diagnostics
LUCD
Lucid Diagnostics (LUCD) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.06
- EPS estimate
- −$0.06
- EPS surprise
- −5.82%
- Revenue surprise
- +2.90%
- Revenue
- $1.5M
- Revenue estimate
- $1.4M
- Reported
- Aug 12, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | −$0.06 | −$0.06 | −5.82% | $1.5M | SEC |
| Q1 2026 | May 13, 2026 | −$0.06 | −$0.07 | −27.27% | $1.3M | SEC |
| Q4 2025 | Mar 25, 2026 | −$0.09 | −$0.10 | −8.70% | $1.5M | SEC |
| Q3 2025 | Nov 12, 2025 | −$0.10 | −$0.10 | −5.26% | $1.2M | SEC |
| Q2 2025 | Aug 12, 2025 | −$0.11 | −$0.10 | +12.28% | $1.2M | SEC |
| Q1 2025 | May 13, 2025 | −$0.15 | −$0.16 | −8.11% | $828,000.00 | SEC |
| Q4 2024 | Mar 24, 2025 | −$0.18 | −$0.19 | −6.74% | $1.2M | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.21 | −$0.20 | +2.91% | $1.2M | SEC |
| Q2 2024 | Aug 12, 2024 | −$0.20 | −$0.20 | +0.00% | $976,000.00 | SEC |
| Q1 2024 | May 13, 2024 | −$0.24 | −$0.99 | −312.50% | $1.0M | SEC |
| Q4 2023 | Mar 25, 2024 | −$0.23 | −$1.33 | −478.26% | $1.0M | SEC |
| Q3 2023 | Nov 13, 2023 | −$0.24 | −$0.22 | +7.37% | $783,000.00 | SEC |
| Q2 2023 | Aug 14, 2023 | −$0.28 | −$0.23 | +18.58% | $159,000.00 | SEC |
| Q1 2023 | May 15, 2023 | −$0.33 | −$0.24 | +26.20% | $446,000.00 | SEC |
| Q4 2022 | Mar 14, 2023 | −$0.33 | −$0.33 | +0.00% | $112,000.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$0.35 | −$0.28 | +20.27% | $76,000.00 | — |
| Q2 2022 | Aug 15, 2022 | −$0.33 | −$0.41 | −23.12% | $0.00 | — |
| Q1 2022 | May 12, 2022 | −$0.26 | −$0.23 | +11.37% | $189,000.00 | — |
Quarterly revenue
Frequently asked questions
When did Lucid Diagnostics (LUCD) last report earnings?
Lucid Diagnostics last reported on Aug 12, 2026, covering fiscal Q2 2026.
Did LUCD beat earnings estimates?
No. Lucid Diagnostics reported EPS of −$0.06 for Q2 2026 against a −$0.06 estimate — a 5.82% miss.
How much revenue did LUCD report last quarter?
Lucid Diagnostics reported $1.5M in revenue for Q2 2026, against a consensus estimate of $1.4M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.